BioSpace News Archive

Biotech Beach

OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

OncoSec Medical Incorporated announced the closing of its previously announced registered direct offering of 1,408,384 shares of its common stock, at a purchase price of $0.945 per share, priced at-the-market under Nasdaq rules.

May 18, 2023
·
7 min read
Biotech Bay

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 18, 2023

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 128,840 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

May 18, 2023
·
1 min read
Biotech Beach

Taro to Release Full Year Results on May 23, 2023

Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for the year ended March 31, 2023, after the close of market on Tuesday, May 23, 2023.

May 18, 2023
·
1 min read
Biotech Bay

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 18, 2023

Ultragenyx Pharmaceutical Inc. reported the grant of non-qualified stock options to purchase an aggregate of 810 shares of common stock of the company and 31,690 restricted stock units of the company’s common stock to 23 newly hired non-executive officers of the company.

May 18, 2023
·
2 min read
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer

Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced a strategic collaboration with UroViu Corporation.

May 18, 2023
·
3 min read
Pharm Country

GenScript Expands Peptide and Oligonucleotide Production Facility in China

GenScript’s new life-science building in Zhenjiang, Jiangsu, China spans 91,310 sq. ft. and is ISO 9001 certified; highly automated clean-room facilities offer fast-turnaround, high-purity oligonucleotide and peptide synthesis service for R&D and preclinical applications.

May 18, 2023
·
3 min read
Drug Development

Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting

Adicet Bio, Inc. announced preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR T cell therapy candidate targeting CD70+ cancers, at the 26th Annual Meeting of the American Society of Gene & Cell Therapy taking place from May 16-20, 2023, in Los Angeles, CA.

May 18, 2023
·
5 min read
BioMidwest

AdventHealth Tampa Launching New OB/GYN Residency Program

AdventHealth Tampa is proud to announce the accreditation of its new Obstetrics and Gynecology Residency Program, helping improve access to women’s healthcare in the Tampa Bay region.

May 18, 2023
·
2 min read
Biotech Bay

Reviva Pharmaceuticals to Present at Upcoming Investor Conferences in May 2023

Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will be presenting at two upcoming investor conferences to be held in May 2023.

May 18, 2023
·
3 min read
Drug Development

Lilly’s peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine

The New England Journal of Medicine published detailed results from Eli Lilly and Company’s phase 2a study of peresolimab in rheumatoid arthritis, in which peresolimab met the primary endpoint for efficacy and had similar rates of adverse events between peresolimab and placebo arms.

May 18, 2023
·
7 min read